Home

Fehlverhalten Verwickle dich Grippe anti met rekrutieren Festung Delle

AACR 2023: YH013, a Novel Bispecific EGFR x MET Antibody-Drug Conjugate, Exhibits Potent Anti-Tumor Efficacy - Biocytogen
AACR 2023: YH013, a Novel Bispecific EGFR x MET Antibody-Drug Conjugate, Exhibits Potent Anti-Tumor Efficacy - Biocytogen

c-Met Monoclonal Antibody (3D4) (18-7366)
c-Met Monoclonal Antibody (3D4) (18-7366)

Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)
Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)

InlB-Dependent Internalization of Listeria Is Mediated by the Met Receptor Tyrosine Kinase: Cell
InlB-Dependent Internalization of Listeria Is Mediated by the Met Receptor Tyrosine Kinase: Cell

c-Met (Cytoplasmic) antibody (25869-1-AP) | Proteintech
c-Met (Cytoplasmic) antibody (25869-1-AP) | Proteintech

Anti-c-Met antibody
Anti-c-Met antibody

Development of a MET-targeted single-chain antibody fragment as an anti-oncogene targeted therapy for breast cancer | SpringerLink
Development of a MET-targeted single-chain antibody fragment as an anti-oncogene targeted therapy for breast cancer | SpringerLink

The NHance® mutation-equipped anti-MET antibody ARGX-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients
The NHance® mutation-equipped anti-MET antibody ARGX-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients

Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cancer Cell International | Full Text
Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cancer Cell International | Full Text

Met (c Met) Polyclonal Antibody – Bioss
Met (c Met) Polyclonal Antibody – Bioss

Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)
Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)

Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer - ScienceDirect
Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer - ScienceDirect

Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition | Journal of Nuclear Medicine
Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition | Journal of Nuclear Medicine

Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam
Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam

Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for EGFR-mutated Non-small Cell Lung Cancer - touchONCOLOGY
Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for EGFR-mutated Non-small Cell Lung Cancer - touchONCOLOGY

Amivantamab (JNJ-61186372) is a Human EGFR-MET Bispecific Antibody - Network of Cancer Research
Amivantamab (JNJ-61186372) is a Human EGFR-MET Bispecific Antibody - Network of Cancer Research

7 Inhibition of MET signaling in cancer therapies. Anti-HGF monoclonal... | Download Scientific Diagram
7 Inhibition of MET signaling in cancer therapies. Anti-HGF monoclonal... | Download Scientific Diagram

Anti-MET Antibody (PACO01060) | WB
Anti-MET Antibody (PACO01060) | WB

Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer - ScienceDirect
Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer - ScienceDirect

c-Met (Cytoplasmic) antibody (25869-1-AP) | Proteintech
c-Met (Cytoplasmic) antibody (25869-1-AP) | Proteintech

JPM | Free Full-Text | MET Gene Dysregulation as a Promising Therapeutic Target in Lung Cancer—A Review
JPM | Free Full-Text | MET Gene Dysregulation as a Promising Therapeutic Target in Lung Cancer—A Review

Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification | BMC Cancer | Full Text
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification | BMC Cancer | Full Text

HGF-MET inhibitors and potential sites of action. Abbreviations: HGF,... | Download Scientific Diagram
HGF-MET inhibitors and potential sites of action. Abbreviations: HGF,... | Download Scientific Diagram

Targeting MET in Lung Cancer: Will Expectations Finally Be MET? - ScienceDirect
Targeting MET in Lung Cancer: Will Expectations Finally Be MET? - ScienceDirect